Stages of development

Third stage of development

  • The third stage of development may include more biomarkers, in addition to highly sensitive Troponin, in order to be able to test several markers at the same time, so-called multiplex. This further development of the Point-Of-Care Testing (POCT) system has been evaluated together with TTP, which indicated that it would be technically possible to implement, but would require more time and resources.

Previous stages of development

  • The first stage of development, which was completed in March 2018, included verification of the platform's functionality.
  • The second stage of development, which was completed in August 2020, included the product development of a number of individual functional processes, so-called “core functionalities”, that are necessary to be able to test highly sensitive Troponin on the company's POC platform.